Cornelia Eckert
Papers
1
Total Citations
4
H-Index
1
About
Cornelia Eckert is a leading researcher in the field of microfluidic diagnostics and cancer monitoring, with a particular focus on minimal residual disease (MRD) detection. Her most-cited work, "The MRD disk: automated minimal residual disease monitoring by highly sensitive centrifugal microfluidic multiplex qPCR" (2020), introduces a groundbreaking proof-of-principle platform that automates and standardizes highly sensitive, multiplexed quantitative PCR assays. This innovation addresses critical challenges in repetitive, longitudinal cancer monitoring, where reproducibility and sensitivity are paramount. By integrating centrifugal microfluidics, Eckert’s MRD disk enables automated, high-throughput analysis, reducing manual error and enhancing clinical reliability. Although her citation count is currently modest (4 citations for this key paper), the work represents a significant step toward practical, point-of-care tools for tracking cancer recurrence. Her contributions are particularly valuable for standardizing MRD assays, which are essential for personalized treatment adjustments and improving patient outcomes. Eckert’s research bridges engineering and oncology, offering a scalable solution that could transform how clinicians monitor disease progression and response to therapy. Her work underscores the potential of microfluidics to democratize advanced diagnostic capabilities, making them accessible in routine clinical settings.
Research Focus
Key Achievements
Top Papers
- 1